Chongqing University Cancer Hospital
Clinical trials sponsored by Chongqing University Cancer Hospital, explained in plain language.
-
New Triple-Threat attack on advanced throat cancer enters testing
Disease control Recruiting nowThis study is testing whether adding two drugs, envafolimab and endostatin, to standard chemotherapy and radiation works better for people with locally advanced nasopharyngeal cancer. It will involve about 30 patients who have not had prior treatment. The goal is to see if this c…
Phase: PHASE2 • Sponsor: Chongqing University Cancer Hospital • Aim: Disease control
Last updated Apr 04, 2026 05:21 UTC
-
New hope for aggressive lung cancer: trial tests Triple-Threat treatment
Disease control Recruiting nowThis study is testing whether adding a new immunotherapy drug (tislelizumab) to standard chemotherapy, followed by targeted chest radiation, can better control advanced small cell lung cancer. The trial will enroll 36 newly diagnosed patients to see if this combination helps keep…
Phase: PHASE2 • Sponsor: Chongqing University Cancer Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Surgical approach tested to extend lives of women with advanced cervical cancer
Disease control Recruiting nowThis study is testing whether removing lymph nodes before standard treatment helps women with advanced cervical cancer live longer without their cancer getting worse. Researchers will compare two approaches: standard treatment alone versus surgery to remove lymph nodes followed b…
Phase: NA • Sponsor: Chongqing University Cancer Hospital • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New 'Film' aims to stop sick kids from vomiting during cancer treatment
Symptom relief Recruiting nowThis study is testing if a special dissolving film containing the drug ondansetron can safely prevent vomiting in children (aged 1-14) who are receiving radiation therapy for cancer. It aims to find a better way to manage this common and distressing side effect. The trial will in…
Phase: PHASE4 • Sponsor: Chongqing University Cancer Hospital • Aim: Symptom relief
Last updated Mar 30, 2026 14:30 UTC